# TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine

> **NCT00385008** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Combination Product (sumatriptan succinate / naproxen sodium)
- **DRUG:** RELPAX(eletriptan) 40mg Tablet

## Key facts

- **NCT ID:** NCT00385008
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09-13
- **Primary completion:** 2006-11-24
- **Final completion:** 2006-11-24
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385008, "TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00385008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*